Companies / Turkey

Abdi Ibrahim Looks To Algeria

December 2006 | Company Finance Alert

Printable version
Bookmark

Abdi Ibrahim claims to be Turkey's leading pharmaceutical firm, and already has product alliances with foreign players including

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Actavis Launching New Generics

Companies / Turkey Icelandic drugmaker Actavis has launched three new generic drugs in Turkey, as the company continues to expand in the country. The three products include Xetanor (paroxetine), an antidepressant in SSRI...

October 2006

Roche Compensates Government

Companies / Turkey Swiss drugmaker Roche has paid compensation of EUR1.4mn (US$1.76mn) to the Turkish Health Ministry after allegedly causing the government to incur substantial losses by overcharging for drugs. However,...

October 2006

Turkey's Abdi Ibrahim, India's Strides Agree Alliance

Companies / Turkey Indian generics firm Strides has agreed a joint venture with Turkish drugmaker Abdi Ibrahim to sell its products in Turkey and in neighbouring countries. The Turkish drug market is currently worth around...

June 2006

Interest In Selcuk Ecza Surges

Companies / Turkey Turkish drug distributor Selcuk Ecza has seen demand for shares soar after its US$180mn offering for a 20% stake in the company. According to reports, the IPO was 9.65 times oversubscribed. The company...

May 2006

Sanovel Ilac Opens New Plant

Companies / Turkey Turkish drugmaker Sanovel Ilac will open its new TRY192mn (US$144.85mn) production facility shortly. Construction on the 120,000 m2 plant began in 2001and when fully operational it will have an annual...

April 2006